Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12832240
[patent_doc_number] => 20180169252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => TAGGABLE HETEROAROMATIC DRUGS AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/737247
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737247
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737247 | Taggable heteroaromatic drugs and conjugates thereof | Jun 15, 2016 | Issued |
Array
(
[id] => 12036504
[patent_doc_number] => 09814715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Liver X receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 15/182749
[patent_app_country] => US
[patent_app_date] => 2016-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21432
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182749
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/182749 | Liver X receptor modulators | Jun 14, 2016 | Issued |
Array
(
[id] => 14793957
[patent_doc_number] => 10399970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Pyrridinobenzodiazepine and benzopyrridodiazecine compounds
[patent_app_type] => utility
[patent_app_number] => 15/579148
[patent_app_country] => US
[patent_app_date] => 2016-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29368
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 966
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579148
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579148 | Pyrridinobenzodiazepine and benzopyrridodiazecine compounds | Jun 8, 2016 | Issued |
Array
(
[id] => 11324874
[patent_doc_number] => 20160355486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'METHODS OF MAKING PROTEIN DEACETYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/176826
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9177
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15176826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/176826 | Methods of making protein deacetylase inhibitors | Jun 7, 2016 | Issued |
Array
(
[id] => 11083700
[patent_doc_number] => 20160280664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'Cyclopropanecarboxamido-Substituted Aromatic Compounds as Anti-tumor Agents'
[patent_app_type] => utility
[patent_app_number] => 15/173720
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28474
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15173720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/173720 | Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents | Jun 5, 2016 | Issued |
Array
(
[id] => 12837127
[patent_doc_number] => 20180170882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => N-METHYLBENZIMIDAZOLES AS MIDH1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/580372
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580372
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580372 | N-Methylbenzimidazoles as mIDH1 inhibitors | Jun 2, 2016 | Issued |
Array
(
[id] => 11857869
[patent_doc_number] => 09737536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Pyrimidinyl-diazospiro compounds'
[patent_app_type] => utility
[patent_app_number] => 15/163845
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16980
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163845
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163845 | Pyrimidinyl-diazospiro compounds | May 24, 2016 | Issued |
Array
(
[id] => 11908194
[patent_doc_number] => 09776998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Synthesis of heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 15/161103
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12876
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161103 | Synthesis of heterocyclic compounds | May 19, 2016 | Issued |
Array
(
[id] => 11060703
[patent_doc_number] => 20160257665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'SUBSTITUTED AZINES AS PESTICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/156406
[patent_app_country] => US
[patent_app_date] => 2016-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10012
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156406 | Substituted azines as pesticides | May 16, 2016 | Issued |
Array
(
[id] => 11901937
[patent_doc_number] => 09771361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Inhibitors of influenza viruses replication'
[patent_app_type] => utility
[patent_app_number] => 15/150459
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 39533
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/150459 | Inhibitors of influenza viruses replication | May 9, 2016 | Issued |
Array
(
[id] => 12724114
[patent_doc_number] => 20180133205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
[patent_app_type] => utility
[patent_app_number] => 15/570246
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570246 | Compound impurities and methods of detecting same | May 1, 2016 | Issued |
Array
(
[id] => 11750348
[patent_doc_number] => 09708351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Alkenes as alkyne equivalents in radical cascades terminated by fragmentations'
[patent_app_type] => utility
[patent_app_number] => 15/143669
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 27881
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/143669 | Alkenes as alkyne equivalents in radical cascades terminated by fragmentations | May 1, 2016 | Issued |
Array
(
[id] => 12680782
[patent_doc_number] => 20180118760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/569191
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569191 | Substituted polycyclic pyridone derivatives and prodrugs thereof | Apr 26, 2016 | Issued |
Array
(
[id] => 12680782
[patent_doc_number] => 20180118760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/569191
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569191 | Substituted polycyclic pyridone derivatives and prodrugs thereof | Apr 26, 2016 | Issued |
Array
(
[id] => 12680782
[patent_doc_number] => 20180118760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/569191
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569191 | Substituted polycyclic pyridone derivatives and prodrugs thereof | Apr 26, 2016 | Issued |
Array
(
[id] => 12680782
[patent_doc_number] => 20180118760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/569191
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569191 | Substituted polycyclic pyridone derivatives and prodrugs thereof | Apr 26, 2016 | Issued |
Array
(
[id] => 11083732
[patent_doc_number] => 20160280698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/137922
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 10970
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137922 | Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor | Apr 24, 2016 | Issued |
Array
(
[id] => 11114842
[patent_doc_number] => 20160311816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING KINASES'
[patent_app_type] => utility
[patent_app_number] => 15/136497
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136497
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136497 | Compositions and methods for inhibiting kinases | Apr 21, 2016 | Issued |
Array
(
[id] => 11737076
[patent_doc_number] => 09701649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Crystal modifications of elobixibat'
[patent_app_type] => utility
[patent_app_number] => 15/134583
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11688
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134583
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134583 | Crystal modifications of elobixibat | Apr 20, 2016 | Issued |
Array
(
[id] => 11032865
[patent_doc_number] => 20160229822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'CRYSTAL MODIFICATIONS OF ELOBIXIBAT'
[patent_app_type] => utility
[patent_app_number] => 15/134586
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11620
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134586 | Crystal modifications of elobixibat | Apr 20, 2016 | Issued |